The energy margin strategy for reducing dose variation due to setup uncertainty in intensity modulated proton therapy (IMPT) delivered with distal edge tracking (DET)

Journal of Applied Clinical Medical Physics

Volumn 13, Issue 5, 2012, Pages 170-180

  Zhang, Miao ^a   Flynn, Ryan T ^b   Mo, Xiaohu ^c   Mackie, Thomas Rock ^c  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Distal edge tracking; EM; Intensity modulated proton therapy; Monte Carlo

Indexed keywords

EID: 84867068190     PISSN: None     EISSN: 15269914     Source Type: Journal    
DOI: 10.1120/jacmp.v13i5.3863     Document Type: Article

References (34)

1. Nill S, Bortfeld T, Oelfke U. Inverse planning of intensity modulated proton therapy. Z Med Phys. 2004;14(1):35-40.
2. Lomax A. Intensity modulation methods for proton radiotherapy. Phys Med Biol. 1999;44(1):185-205.
3. Lomax A, Goitein M, Adams J. Intensity modulation in radiotherapy: photons versus protons in the paranasal sinus. Radiother Oncol. 2003;66(1):11-18.
4. Thorwarth D, Soukup M, Alber M. Dose painting with IMPT, helical tomotherapy and IMXT: a dosimetric comparison. Radiother Oncol. 2008;86(1):30-34.
5. Flynn R, Bowen S, Bentzen S, Mackie TR, Jeraj R. Intensity-modulated x-ray (IMXT) versus proton (IMPT) therapy for theragnostic hypoxia-based dose painting. Phys Med Biol. 2008;53(15):4153-67.
6. Zhang X, Li Y, Pan X, et al. Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study. Int J Radiat Oncol Biol Phys. 2010;77(2):357-66.
7. Weber DC, Rutz HP, Bolsi A, et al. Spot scanning proton therapy in the curative treatment of adult patients with sarcoma: the Paul Scherrer institute experience. Int J Radiat Oncol Biol Phys. 2007;69(3):865-71.
8. Ares C, Hug E, Lomax A, et al. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report. Int J Radiat Oncol Biol Phys. 2009;75(4):1111-18.
9. Pedroni E, Bohringer T, Coray A, et al. Initial experience of using an active beam delivery technique at PSI. Strahlenther Onkol. 1999;175(Suppl 2):18-20.
10. Deasy JO, Shepard D, Mackie TR. Distal edge tracking: a proposed delivery method for conformal proton therapy using intensity modulation. In: Leavitt DD and Starkschall GS, editors. Proceedings XIIth ICCR (Salt Lake City, UT). Madison, WI: Medical Physics Publishing; 1997.
11. Lomax A J, Bohringer T, Bolsi A, et al. Treatment planning and verification of proton therapy using spot scanning: initial experiences. Med Phys. 2004;31(11):3150-57.
12. Gillin M, Sahoo N, Bues M, et al. Commissioning of the discrete spot scanning proton beam delivery system at the University of Texas MD Anderson Cancer Center, Proton Therapy Center, Houston. Med Phys. 2010;37(1):154-63.
13. Flynn R, Barbee D, Mackie T, Jeraj R. Comparison of intensity modulated x-ray therapy and intensity modulated proton therapy for selective subvolume boosting: a phantom study. Phys Med Biol. 2007;52(20):6073-92.
14. Oelfke U and Bortfeld T. Optimization of physical dose distributions with hadron beams: comparing photon IMXT with IMPT. Technol Cancer Res Treat. 2003;2(5):401-12.
15. Caporaso GJ, Mackie TR, Sampayan S, et al. A compact linac for intensity modulated proton therapy based on a dielectric wall accelerator. Phys Med. 2008;24(2):98-101.
16. Lomax AJ. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions. Phys Med Biol. 2008;53(4):1043-56.
17. Meyer J, Bluett J, Amos R, et al. Spot scanning proton beam therapy for prostate cancer: treatment planning technique and analysis of consequences of rotational and translational alignment errors. Int J Radiat Oncol Biol Phys. 2010;78(2):428-34.
18. Cabal G and Jaekel O. Towards a novel approach for PTV definition in particle therapy. Proceedings of the 49th Conference of the Particle Therapy Co-operative Group, Gunma, Japan. PTCOG. 2010.
19. Pflugfelder D, Wilkens J, Szymanowski H, Oelfke U. Quantifying lateral tissue heterogeneities in hadron therapy. Med Phys. 2007;34(4):1506-13.
20. Pflugfelder D, Wilkens J, Oelfke U. Worst case optimization: a method to account for uncertainties in the optimization of intensity modulated proton therapy. Phys Med Biol. 2008;53(6):1689-700.
21. Unkelbach J, Bortfeld T, Martin BC, Soukup M. Reducing the sensitivity of IMPT treatment plans to setup errors and range uncertainties via probabilistic treatment planning. Med Phys. 2009;36(1):149-63.
22. Fredrikkson A, Forsgren A, Hardemark B. Minimax optimization for handling range and setup uncertainties in proton therapy. Med Phys. 2011;38(3):1672-84.
23. Chen W, Unkelbach J, Trofimov A, et al. Including robustness in multi-criteria optimization for intensity-modulated proton therapy. Phys Med Bio. 2012;57(3);591-608.
24. Urie M, Goitein M, Wagner M. Compensating for heterogeneities in proton radiation therapy. Phys Med Biol. 1984;29(5):553-66.
25. ICRU. Prescribing, recording, and reporting proton beam therapy. ICRU Report 78. Bethesda, MD: ICRU; 2007.
26. Agostinelli S, Allison J, Amako K, et al. GEANT4-a simulation toolkit. Nucl Instrum Meth A. 2003;506(3):250-303.
27. Kimstrand P, Tilly N, Ahnesjo A, Traneus E. Experimental test of Monte Carlo proton transport at grazing incidence in GEANT4, FLUKA and MCNPX. Phys Med Biol. 2008;53(4):1115-29.
28. Paganetti H, Jiang H, Lee SY, Kooy HM. Accurate Monte Carlo simulations for nozzle design, commissioning and quality assurance for a proton radiation therapy facility. Med Phys. 2004;31(7):2107-18.
29. Paganetti H, Jiang H, Parodi K, Slopsema R, Engelsman M. Clinical implementation of full Monte Carlo dose calculation in proton beam therapy. Phys Med Biol. 2008;53(17):4825-53.
30. NIST. ASTAR and PSTAR materials. Available from: http://physics.nist.gov/cgi-bin/Star/compos.pl?ap
31. Shepard DM, Olivera GH, Reckwerdt PJ, Mackie TR. Iterative approaches to dose optimization in tomotherapy. Phys Med Biol. 2000;45(1):69-90.
32. Hurkmans CW, Remeijer P, Lebesque JV, Mijnheer BJ. Set-up verification using portal imaging; review of current clinical practice. Radiother Oncol. 2001;58(2):105-20.
33. Kutcher GJ and Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys. 1989;16(6):1623-30.
34. Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function Int J Radiat Oncol Biol Phys. 1991;21(1):123-35.